vs

Side-by-side financial comparison of GENCO SHIPPING & TRADING LTD (GNK) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

GENCO SHIPPING & TRADING LTD is the larger business by last-quarter revenue ($109.9M vs $75.5M, roughly 1.5× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 10.8%). GENCO SHIPPING & TRADING LTD produced more free cash flow last quarter ($15.6M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -3.3%).

Genco Shipping & Trading Ltd is a global dry bulk shipping enterprise that operates a diversified fleet of bulk carriers, transporting essential commodities including iron ore, coal, grain, and steel products across major international trade routes, serving industrial, manufacturing, and commodity trading clients worldwide.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

GNK vs PBYI — Head-to-Head

Bigger by revenue
GNK
GNK
1.5× larger
GNK
$109.9M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+16.9% gap
PBYI
27.7%
10.8%
GNK
More free cash flow
GNK
GNK
$1.2M more FCF
GNK
$15.6M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-3.3%
GNK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GNK
GNK
PBYI
PBYI
Revenue
$109.9M
$75.5M
Net Profit
$15.4M
Gross Margin
69.3%
Operating Margin
17.3%
22.7%
Net Margin
14.0%
Revenue YoY
10.8%
27.7%
Net Profit YoY
21.6%
EPS (diluted)
$0.36
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GNK
GNK
PBYI
PBYI
Q4 25
$109.9M
$75.5M
Q3 25
$79.9M
$54.5M
Q2 25
$80.9M
$52.4M
Q1 25
$71.3M
$46.0M
Q4 24
$99.2M
$59.1M
Q3 24
$99.3M
$80.5M
Q2 24
$107.0M
$47.1M
Q1 24
$117.4M
$43.8M
Net Profit
GNK
GNK
PBYI
PBYI
Q4 25
$15.4M
Q3 25
$-1.1M
$8.8M
Q2 25
$-6.8M
$5.9M
Q1 25
$-11.9M
$3.0M
Q4 24
$12.7M
Q3 24
$21.5M
$20.3M
Q2 24
$23.5M
$-4.5M
Q1 24
$18.8M
$-4.8M
Gross Margin
GNK
GNK
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
GNK
GNK
PBYI
PBYI
Q4 25
17.3%
22.7%
Q3 25
3.1%
17.6%
Q2 25
-5.3%
12.7%
Q1 25
-13.7%
8.7%
Q4 24
14.7%
22.6%
Q3 24
24.2%
27.4%
Q2 24
24.6%
-4.6%
Q1 24
18.8%
-5.3%
Net Margin
GNK
GNK
PBYI
PBYI
Q4 25
14.0%
Q3 25
-1.3%
16.2%
Q2 25
-8.4%
11.2%
Q1 25
-16.7%
6.5%
Q4 24
12.8%
Q3 24
21.6%
25.2%
Q2 24
21.9%
-9.6%
Q1 24
16.0%
-11.0%
EPS (diluted)
GNK
GNK
PBYI
PBYI
Q4 25
$0.36
$0.26
Q3 25
$-0.02
$0.17
Q2 25
$-0.16
$0.12
Q1 25
$-0.28
$0.06
Q4 24
$0.29
$0.40
Q3 24
$0.49
$0.41
Q2 24
$0.54
$-0.09
Q1 24
$0.43
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GNK
GNK
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$55.5M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$896.5M
$130.3M
Total Assets
$1.1B
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GNK
GNK
PBYI
PBYI
Q4 25
$55.5M
$97.5M
Q3 25
$90.0M
$94.4M
Q2 25
$35.4M
$96.0M
Q1 25
$30.2M
$93.2M
Q4 24
$43.7M
$101.0M
Q3 24
$46.7M
$96.7M
Q2 24
$42.0M
$96.8M
Q1 24
$48.4M
$107.2M
Total Debt
GNK
GNK
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
GNK
GNK
PBYI
PBYI
Q4 25
$896.5M
$130.3M
Q3 25
$885.9M
$115.3M
Q2 25
$891.6M
$104.7M
Q1 25
$903.2M
$97.1M
Q4 24
$926.7M
$92.1M
Q3 24
$929.9M
$71.1M
Q2 24
$921.8M
$48.5M
Q1 24
$915.1M
$51.0M
Total Assets
GNK
GNK
PBYI
PBYI
Q4 25
$1.1B
$216.3M
Q3 25
$1.1B
$202.9M
Q2 25
$1.0B
$194.9M
Q1 25
$1.0B
$196.2M
Q4 24
$1.1B
$213.3M
Q3 24
$1.0B
$220.7M
Q2 24
$1.1B
$205.0M
Q1 24
$1.1B
$214.1M
Debt / Equity
GNK
GNK
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GNK
GNK
PBYI
PBYI
Operating Cash FlowLast quarter
$15.9M
$14.4M
Free Cash FlowOCF − Capex
$15.6M
$14.4M
FCF MarginFCF / Revenue
14.2%
19.1%
Capex IntensityCapex / Revenue
0.3%
0.0%
Cash ConversionOCF / Net Profit
1.03×
TTM Free Cash FlowTrailing 4 quarters
$28.7M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GNK
GNK
PBYI
PBYI
Q4 25
$15.9M
$14.4M
Q3 25
$7.7M
$9.7M
Q2 25
$5.4M
$14.1M
Q1 25
$2.9M
$3.6M
Q4 24
$30.0M
$15.6M
Q3 24
$35.6M
$11.0M
Q2 24
$29.0M
$1.0M
Q1 24
$32.3M
$11.2M
Free Cash Flow
GNK
GNK
PBYI
PBYI
Q4 25
$15.6M
$14.4M
Q3 25
$6.5M
$9.7M
Q2 25
$4.3M
$14.1M
Q1 25
$2.3M
$3.6M
Q4 24
$29.3M
$15.6M
Q3 24
$34.7M
$11.0M
Q2 24
$27.9M
$1.0M
Q1 24
$32.0M
FCF Margin
GNK
GNK
PBYI
PBYI
Q4 25
14.2%
19.1%
Q3 25
8.2%
17.7%
Q2 25
5.3%
26.8%
Q1 25
3.2%
7.7%
Q4 24
29.5%
26.4%
Q3 24
34.9%
13.7%
Q2 24
26.1%
2.1%
Q1 24
27.3%
Capex Intensity
GNK
GNK
PBYI
PBYI
Q4 25
0.3%
0.0%
Q3 25
1.5%
0.0%
Q2 25
1.3%
0.0%
Q1 25
0.9%
0.1%
Q4 24
0.7%
0.0%
Q3 24
0.9%
0.0%
Q2 24
1.1%
0.0%
Q1 24
0.2%
0.0%
Cash Conversion
GNK
GNK
PBYI
PBYI
Q4 25
1.03×
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
2.37×
Q3 24
1.66×
0.54×
Q2 24
1.24×
Q1 24
1.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons